DCTH Delcath Total Debt to Capital

This chart of separate_debt_total_eq quotes for Delcath Systems, Inc. (DCTH) is 0.02. The business relies on creating a closed interventional oncology environment using CHEMOSAT, which strictly locks clinics into brand standards. Despite geopolitical risks hindering global testing and deliveries, Delcath Systems, Inc. (DCTH) maintains its first-mover status in liver therapy due to high confidence in HEPZATO.

Delcath Systems, Inc. (DCTH) implements complex local cancer therapy systems while facing regulatory barriers. This debt-to-equity ratio reflects the proportion of borrowed funds within the financing structure. The metric measures financial leverage by dividing total debt by equity. A low debt load is critical given the high costs associated with rolling out treatment protocols. Investors view this margin of safety as a guarantee of business viability.